NS 3763

Discontinued Product

2187 has been discontinued.

View all Kainate Receptors products.
Description: GluK1 selective and non-competitive kainate antagonist
Chemical Name: 4,6-Bis(benzoylamino)-1,3-benzenedicarboxylic acid
Purity: ≥98% (HPLC)
Datasheet
Citations
Reviews (1)
Literature (2)

Biological Activity for NS 3763

Selective non-competitive kainate receptor antagonist; displays selectivity for GluK1 (formerly GLUK5) subunit-containing receptors (IC50 values are 1.6 and > 30 μM for homomeric GluK1 (formerly GLUK5) and GluK2 (formerly GLUK6) receptors respectively). Has minimal activity at AMPA and NMDA receptors (IC50> 30 μM).

Please refer to IUPHAR Guide to Pharmacology for the most recent naming conventions.

Technical Data for NS 3763

M. Wt 404.38
Formula C22H16N2O6
Storage Store at RT
Purity ≥98% (HPLC)
CAS Number 70553-45-6
PubChem ID 4359312
InChI Key UUDYZUDTQPLDDP-UHFFFAOYSA-N
Smiles O=C(C2=CC=CC=C2)NC1=CC(NC(C3=CC=CC=C3)=O)=C(C(O)=O)C=C1C(O)=O

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets for NS 3763

Certificate of Analysis / Product Datasheet
Select another batch:

References for NS 3763

References are publications that support the biological activity of the product.

Christensen et al (2004) In vitro characterization of 5-carboxyl-2,4-di-benzamido-benzoic acid (NS3763), a noncompetitive antagonist of GLUK5 receptors. J.Pharmacol.Exp.Ther. 309 1003 PMID: 14985418

View Related Products by Target

View Related Products by Product Action

View all Kainate Receptor Antagonists

Keywords: NS 3763, NS 3763 supplier, Selective, non-competitive, kainate, antagonists, selective, GLUK5, Glutamate, Kainate, Receptors, iGluR, Ionotropic, NS3763, GluK1, 2187, Tocris Bioscience

Citations for NS 3763

Citations are publications that use Tocris products.

Currently there are no citations for NS 3763.

Reviews for NS 3763

Average Rating: 4 (Based on 1 Review.)

5 Star
0%
4 Star
100%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used NS 3763?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


NS 3763 was studied to determine its NMDA effect:Product works well and the results publishable.
By Sadequl Islam on 10/12/2018
Assay Type: In Vitro
Species: Human

NS 3763 performed extremely well when tested for NMDA activity. The correlation of NS 3763 was studied in respect to its effect with NMDA regulation.

The NS 3763 cannot be dissolved in aqueous media and must be dissolved in DMSO. For sterile conditions/study, sterile DMSO is mandatory.

review image

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Addiction Poster

Addiction Poster

The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.